why choose us

First received: December 09, 2022

Clinical Trial: WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced or Metastatic Solid Tumors

Study Type: INTERVENTIONAL


Official Title: A Phase 1 (First-In-Human [FIH]), Multi-Site, Dose Escalation and Expansion Study of WTX-330 in Adult Patients With Advanced or Metastatic Solid Tumors or Lymphoma

Brief Summary: A first-in-human, Phase 1, open-label, multicenter study of WTX-330 administered as a monotherapy to patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.

Read more